[Opiatergic mechanisms of antiarrhythmic effect of adaptation].
Lishmanov
Iu B
IuB
Uskina
E V
EV
Maslov
L N
LN
Krylatov
A V
AV
D000222:Adaptation, Physiological / Q000502:physiology*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000503:physiopathology* / Q000517:prevention & control; D002122:Calcium Chloride / Q000633:toxicity; D004220:Disulfides / Q000494:pharmacology; D004723:Endorphins / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004837:Epinephrine / Q000633:toxicity; D008297:Male; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D015260:Neprilysin / Q000037:antagonists & inhibitors; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011957:Receptors, Opioid / Q000502:physiology*
D004220:Disulfides; D004723:Endorphins; D004791:Enzyme Inhibitors; D009292:Narcotic Antagonists; D011957:Receptors, Opioid; C019448:kyotorphin; C074024:RB 101; D010649:Phenylalanine; D009271:Naltrexone; D015260:Neprilysin; C055382:naltrindole; D002122:Calcium Chloride; D004837:Epinephrine
Opiatergicheskie mekhanizmy antiaritmicheskogo éffekta adaptatsii.